BioSpace News Archive

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that Nature Communications has published an article entitled, “Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease.”

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the promotion of Bill Steinkrauss to Chief Financial Officer

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, today unveiled Quest® Lab Stewardship™ powered by hc1®, an innovative new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization.*

Arosa+LivHOME has signed an agreement to acquire LifeLinks, a leading provider of Aging Life Care™ services in Raleigh, NC and Nashville, TN.

During 15-17 September, RaySearch will exhibit its latest advances in oncology software at the American Society for Radiation Oncology 2019 annual meeting in Chicago, USA.

Navitor Pharmaceuticals, Inc., the leader in the discovery and development of mTORC1-targeted therapeutics designed to help patients live longer and healthier lives, announced today the successful completion of three Phase 1 studies for NV-5138, which is in development for patients with depression.

The Board of Directors has appointed Mrs. Elcin Barker Ergun as CEO of Menarini Group.

Today, miniPCR bio™ launched BioBits™, an advanced synthetic biology system that can perform biological experiments without the need for living cells or specialized equipment

Nationwide campaign will take place in October

TRC’s offer is subject to a number of conditions, including TRC’s ability to obtain sufficient financing.